Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
INTRODUCTION:Bile acids (BAs) are the end products of cholesterol metabolism produced by human and gut microbiome co-metabolism. Recent evidence suggests gut microbiota influence pathological features of Alzheimer's disease (AD) including neuroinflammation and amyloid-β deposition. METHOD:Serum...
Main Authors: | Nho, K, Kueider-Paisley, A, Mahmoudian-Dehkordi, S, Arnold, M, Risacher, SL, Louie, G, Blach, C, Baillie, R, Han, X, Kastenmüller, G, Jia, W, Xie, G, Ahmad, S, Hankemeier, T, van Duijn, CM, Trojanowski, JQ, Shaw, LM, Weiner, MW, Doraiswamy, PM, Saykin, AJ, Kaddurah-Daouk, R, Alzheimer'S Disease Neuroimaging Initiative And The Alzheimer Disease Metabolomics Consortium |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2018
|
Similar Items
-
Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers
by: Nho, K, et al.
Published: (2019) -
Random forest prediction of Alzheimer's disease using pairwise selection from time series data
by: Moore, P, et al.
Published: (2019) -
Quantifying uncertainty in brain-predicted age using scalar-on-image quantile regression
by: Palma, M, et al.
Published: (2020) -
Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
by: Stockman, CA, et al.
Published: (2024) -
Generalized reduced rank latent factor regression for high dimensional tensor fields, and neuroimaging-genetic applications
by: Tao, C, et al.
Published: (2016)